{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:21:13Z","timestamp":1762161673682,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["80-84600-98-3002"],"award-info":[{"award-number":["80-84600-98-3002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejca.2021.02.029","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T18:15:02Z","timestamp":1616868902000},"page":"405-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Mainstreaming informed consent for genomic sequencing: A call for action"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-6222","authenticated-orcid":false,"given":"Eline M.","family":"Bunnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-7192","authenticated-orcid":false,"given":"Wybo J.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-8963","authenticated-orcid":false,"given":"Annelien L.","family":"Bredenoord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-4902","authenticated-orcid":false,"given":"Guido","family":"de Wert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-5544","authenticated-orcid":false,"given":"Martina C.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.02.029_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7861\/clinmedicine.14-4-436","article-title":"Mainstreaming genetic testing of cancer predisposition genes","volume":"14","author":"Rahman","year":"2014","journal-title":"Clin Med"},{"key":"10.1016\/j.ejca.2021.02.029_bib2","doi-asserted-by":"crossref","first-page":"29506","DOI":"10.1038\/srep29506","article-title":"Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients","volume":"6","author":"George","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2021.02.029_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10689-019-00122-y","article-title":"Moving into the mainstream: healthcare professionals\u2019 views of implementing treatment focussed genetic testing in breast cancer care","volume":"18","author":"Hallowell","year":"2019","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejca.2021.02.029_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41436-019-0666-z","article-title":"Diagnostic gene sequencing panels: from design to report\u2014a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Bean","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2021.02.029_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s10897-017-0090-y","article-title":"Impact of panel gene testing for hereditary breast and ovarian cancer on patients","volume":"26","author":"Lumish","year":"2017","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.ejca.2021.02.029_bib6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41431-018-0239-7","article-title":"Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms","volume":"26","author":"Vears","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejca.2021.02.029_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jmedgenet-2014-102435","article-title":"Defining and managing incidental findings in genetic and genomic practice","volume":"51","author":"Shkedi-Rafid","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2021.02.029_bib8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","author":"eMERGE Clinical Annotation Working Group","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2021.02.029_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/MOP.0000000000000680","article-title":"The Iceberg Map of germline mutations in childhood cancer: focus on primary immunodeficiencies","volume":"30","author":"Kindler","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ejca.2021.02.029_bib10","first-page":"369","article-title":"Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance","volume":"63","author":"G\u00f3mez","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ejca.2021.02.029_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13046-020-01554-6","article-title":"Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers","volume":"39","author":"Federici","year":"2020","journal-title":"J Exp Clin Canc Res"},{"year":"2008","series-title":"Additional protocol to the convention on human rights and biomedicine, concerning genetic testing for health purposes","key":"10.1016\/j.ejca.2021.02.029_bib12"},{"year":"2017","series-title":"Genomics in mainstream clinical pathways","author":"Burton","key":"10.1016\/j.ejca.2021.02.029_bib13"},{"key":"10.1016\/j.ejca.2021.02.029_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cge.12299","article-title":"Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients","volume":"85","author":"Rigter","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejca.2021.02.029_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12910-017-0207-8","article-title":"Healthcare professionals' and patients' perspectives on consent to clinical genetic testing: moving towards a more relational approach","volume":"18","author":"Samuel","year":"2017","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.ejca.2021.02.029_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","article-title":"A new definition of genetic counseling: national society of genetic counselors\u2019 task force report","volume":"15","author":"National Society of Genetic Counselors\u2019 Definition Taskforce","year":"2006","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.ejca.2021.02.029_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000619","article-title":"Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer","volume":"5","author":"Bijlsma","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2021.02.029_bib18","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/pon.4676","article-title":"Managing unsolicited findings in genomics: a qualitative interview study with cancer patients","volume":"27","author":"Bijlsma","year":"2018","journal-title":"Psycho Oncol"},{"key":"10.1016\/j.ejca.2021.02.029_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bioe.12004","article-title":"Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent","volume":"28","author":"Bunnik","year":"2014","journal-title":"Bioethics"},{"key":"10.1016\/j.ejca.2021.02.029_bib20","article-title":"Advanced cancer patients\u2019 attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study","volume":"26","author":"Liang","year":"2017","journal-title":"Eur J Canc Care"},{"key":"10.1016\/j.ejca.2021.02.029_bib21","article-title":"Decision-making preferences about secondary germline findings that arise from tumor genomic profiling among patients with advanced cancers","volume":"1","author":"Hamilton","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2021.02.029_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11948-016-9755-4","article-title":"Relevant information and informed consent in research: in defense of the subjective standard of disclosure","volume":"23","author":"Dranseika","year":"2017","journal-title":"Sci Eng Ethics"},{"key":"10.1016\/j.ejca.2021.02.029_bib23","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ajmg.a.37256","article-title":"Experiences with obtaining informed consent for genomic sequencing","volume":"167A","author":"Bernhardt","year":"2015","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ejca.2021.02.029_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12920-018-0337-y","article-title":"Adopting clinical genomics: a systematic review of genomic literacy among physicians in cancer care","volume":"11","author":"Ha","year":"2018","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.ejca.2021.02.029_bib25","article-title":"Information sources used by oncologists to understand multi-marker tumor panel tests for cancer patients","author":"Buckenmaier","year":"2020","journal-title":"J Canc Educ"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:32:22Z","timestamp":1760733142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921001313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":25,"alternative-id":["S0959804921001313"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.02.029","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mainstreaming informed consent for genomic sequencing: A call for action","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}